封面
市场调查报告书
商品编码
1197317

交互式伤口敷料市场——增长、趋势和预测 (2023-2028)

Interactive Wound Dressing Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计交互式伤口敷料市场在预测期内的复合年增长率为 5.97%。

交互式伤口敷料市场早期受到 COVID-19 大流行的严重影响,因为主要城市的严格封锁措施减少了交通并减少了伤害。我是。 但由于放宽了限制,生意正在好转。 随着新产品的推出和慢性伤口的增加,交互式伤口敷料的销售额在过去两年中有所增加。

主要亮点

  • 技术进步、越来越多的慢性伤口和越来越多的外科手术是交互式伤口敷料市场的主要驱动力。 例如,根据国际糖尿病联合会 (IDF) 的数据,到 2022 年将有大约 5.37 亿成年人(20-79 岁)患有糖尿病。 糖尿病患者总数预计到 2030 年将增加到 6.43 亿,到 2045 年将增加到 7.83 亿。
  • 糖尿病的流行有助于市场增长,因为它增加了患糖尿病足溃疡的风险。 此外,根据 IDF 2021 报告,糖尿病足溃疡影响全球 40-6000 万人。 因此,糖尿病足溃疡患病率的增加可能会推动市场增长。 因此,糖尿病足溃疡、静脉性腿部溃疡和压力性溃疡等导致慢性伤口的几种生活方式疾病的患病率增加,估计将在未来几年推动交互式伤口敷料市场的增长。这是关键因素之一。
  • 此外,交互式伤口敷料的需求量很大,因为它们为伤口癒合提供了潮湿的环境。 这些敷料有助于更快的再上皮化和胶原蛋白合成,通过在伤口床中产生缺氧来促进血管生成,降低伤口床的 pH 值,并减少伤口感染。
  • Wiley 于 2021 年 6 月发表的一篇文章讨论了智能伤口敷料作为伤口护理管理新策略的重要性,以及不同类型的智能敷料在帮助伤口癒合方面的功效。文章指出正在进行调查研究。 交互式伤口敷料的这种进步将导致对伤口癒合产品的需求增加,从而在预测期内刺激市场增长。
  • 随着主要参与者通过合併、产品发布和收购实现其战略目标,交互式伤口癒合市场也在不断扩大。 例如,2021 年 9 月,美国食品和药物管理局 (USFDA) 批准了 Omeza Collagen Matrix,这是一种用于治疗慢性伤口的联合药物和器械基质。 该批准是通过 FDA 的 510(k) 上市前通知流程获得的。 设计基于与规则和不规则伤口床的密切接触,以帮助自然伤口癒合。 该产品适用于单位剂量小瓶中的非治疗应用。
  • 因此,由于技术进步、慢性伤口患病率上升以及手术程序增加,预计交互式伤口敷料市场在预测期内将呈现增长。 然而,高昂的治疗成本和批准新技术的严格监管框架是阻碍市场增长的因素。

交互式伤口敷料市场趋势

交互式伤口敷料市场预计在预测期内在慢性伤口部分增长

  • 慢性伤口是指 12 週后仍未癒合的伤口。 减缓伤口癒合的主要因素包括糖尿病、感染和长期炎症。 糖尿病会影响对伤口癒合至关重要的皮肤微环境。 足部溃疡等慢性伤口在糖尿病患者中很常见。 例如,据 Mission Regional Medical Centers (MRCM's) 称,目前估计有 670 万人患有慢性伤口。 这一数字预计在未来十年内将增长 2% 以上。
  • 据估计,慢性伤口每年给医疗保健系统造成的损失超过 500 亿美元。 交互式伤口护理的目的是预防慢性伤口并更快、更便宜地治疗患者。 因此,考虑到交互式伤口治疗管理的好处,预计该市场将在预测期内出现增长。
  • 此外,政府和私营部门在伤口护理方面的努力可能会促进市场增长。 例如,2022 年 9 月,伤口护理利益相关者联盟宣布伤口护理利益相关者联盟将开发皮肤伤口细胞和/或要求医疗保险和医疗补助服务中心 (CMS) 更新基于组织的产品的不当支付做法( CTP,或“皮肤替代品”)。
  • 因此,此类与交互式伤口护理相关的建议可能会加深对伤口护理的理解,并在预测期内促进市场增长。 此外,为了保持市场竞争力,市场参与者正在积极开发新产品,推动市场增长。
  • Winner Medical 是先进伤口护理敷料的领先 OEM(原始设备製造)和 ODM(原始设备设计)製造商。 该公司的伤口护理产品在 110 多个国家/地区广泛使用,作为管理糖尿病、行动不便、静脉疾病、外伤、烧伤、侵入性手术等急性和慢性伤口的领先解决方案。 Winner在2022年欧洲伤口管理协会(EWMA)上展示了一整套最□□新和行业领先的伤口护理解决方案,包括透明薄膜敷料、带SAF的边缘硅泡沫敷料、抗菌系列产品和新型CMC敷料。
  • 此外,交通事故和伤亡人数的增加是造成慢性伤口的主要原因,预计这将推动对交互式伤口敷料的需求并促进市场增长。 例如,根据英国政府的 2021 年更新,2021 年英国道路交通伤亡报告中有 133 例深穿透伤。
  • 由于慢性伤口的增加以及政府和私营部门与伤口癒合相关的举措,预计慢性伤口部分在预测期内将会增长。

预计在预测期内北美的交互式伤口敷料市场将增长

  • 由于慢性伤口患病率增加、医疗基础设施不断发展以及外科手术增多等因素,预计北美的交互式伤口敷料市场将出现增长。 特别是在美国,糖尿病患者的比例越来越高,糖尿病溃疡可能会增加。
  • 根据 IDF 2021 年发布的数据,2021 年加拿大 0-14 岁儿童的糖尿病发病率(每 10 万人)约为 37.9%。 到 2021 年,加拿大约有 300 万 20-79 岁的成年人患有糖尿病。 因此,由于加拿大糖尿病负担日益加重,交互式伤口护理敷料市场有望在预测期内实现健康增长。
  • 竞争对手、收购和合併的存在推动了市场增长。 例如,2022 年 3 月,ConvaTec 医疗产品和技术业务集团收购了美国医疗设备公司 Triad Life Sciences。 Triad 团队目前的产品组合和产品线已转移到 ConvaTec 的高级伤口护理 (AWC) 业务,现称为 ConvaTec Advanced Tissue Technologies。
  • 2022 年 10 月,Collagen Matrix 收购了 Polyganics。 Polyganics 是一家开发和製造生物可吸收医疗器械的医疗技术公司。 此次收购扩大了公司用于胶原蛋白基质骨骼和组织修復的生物可吸收解决方案和技术平台的产品组合,开闢了新的市场和临床机会。
  • 因此,由于慢性伤口的增加、医疗保健基础设施的加强以及外科手术的增加,预计北美的交互式伤口敷料市场在预测期内将会扩大。

交互式伤口敷料市场竞争对手分析

大多数交互式伤口敷料产品均由世界领先的公司生产,市场竞争激烈。 拥有更多研究资金和更好的分销系统的市场领导者正在市场中站稳脚跟。 主要参与者包括 B. Braun Melsungen AG、3M、Cardinal Health, Inc、Smith & Nephew 和 Coloplast。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 压疮和糖尿病足的发病率增加
    • 手术次数增加
    • 交互式伤口敷料研究和技术进步
  • 市场製约因素
    • 高级交互式伤口敷料成本高
    • 严格的监管政策
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分(基于价值的市场规模:100 万美元)

  • 按类型
    • 半透膜敷料
    • 半透性泡沫敷料
    • 水凝胶
  • 通过使用
    • 急性伤口
    • 慢性伤口
  • 最终用户
    • 医院和诊所
    • 门诊手术中心
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • 3M
    • B. Braun Melsungen AG
    • Cardinal Health, Inc
    • Coloplast
    • Integra Lifesciences
    • Johnson & Johnson
    • MediWound
    • Seton Pharmaceuticals
    • Smith & Nephew
    • PAUL HARTMANN AG
    • Molnlycke Health Care AB
    • Mativ Holdings(Scapa)

第7章 市场机会与今后动向

简介目录
Product Code: 67463

The interactive wound dressing market is expected to register a CAGR of 5.97% over the forecast period.

The interactive wound dressing market was severely affected by the COVID-19 pandemic in the initial phases as strict lockdown measures across major cities resulted in less transportation or less incidence of injuries. However, the business has been recovering since the limitations were relaxed. Sales of interactive wound dressings have increased over the past two years, new products have also been introduced, and chronic wounds are increasingly common.

Key Highlights

  • Technological advances, the rising prevalence of chronic wounds, and an increasing number of surgical procedures mainly drive the interactive wound dressing market. For instance, according to International Diabetic Federation (IDF), in 2022, approximately 537 million adults (20-79 years) will be living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
  • The prevalence of diabetes increases the risk of diabetic foot ulcers, thus contributing to the market's growth. Moreover, as per the IDF 2021 report, diabetic foot ulcers affected 40 to 60 million people globally. As a result, the market is likely to grow due to the increased prevalence of diabetic foot ulcers. Hence, the growing prevalence of several lifestyle disorders leading to chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, is one of the key factors estimated to encourage the growth of the interactive wound dressing market in the coming years.
  • Moreover, interactive wound dressings are in high demand as these dressings provide a moist environment for wound healing. These dressings help in faster re-epithelialization, and collagen synthesis, promote angiogenesis by creating hypoxia to the wound bed, and decrease wound bed pH, which reduces wound infection.
  • An article published in June 2021 by Wiley stated ongoing studies investigating the significance of smart wound dressings as an emerging strategy for wound care management and the effectiveness of different smart dressing types for aiding wound healing. As a result of these advancements in interactive wound dressing, the need for wound healing products increases, spurring market growth during the forecast period.
  • The market for interactive wound healing is also growing as key players carry out their strategic goals through mergers, product launches, and acquisitions. For instance, in September 2021, the United States Food and Drug Administration (USFDA) cleared the Omeza Collagen Matrix, a drug-device combination matrix for chronic wound care. The approval was granted through the FDA 510(k) premarket notification process. The design is based on intimate contact with regular and irregular wound beds to aid natural wound healing. The product is a no-prep application accessible in unit dose vials.
  • Hence, the interactive wound dressing market is anticipated to witness growth during the forecast period due to technological advancements, the rising prevalence of chronic wounds, and an increasing number of surgical procedures. However, the high cost associated with the treatment and stringent regulatory framework for approval of the new technologies serve as factors that hinder the market growth.

Interactive Wound Dressing Market Trends

Chronic Wounds Segment is Expected to Witness a Growth in the Interactive Wound Dressing Market Over the Forecast Period

  • Chronic wounds are wounds that remain unhealed even after 12 weeks. The main factors delaying wound repair include diabetes, infections, and long-term inflammation. Diabetes mellitus affects the skin's microenvironment, essential for wound healing. Chronic wounds such as foot ulcers are prevalent among the population with diabetes. For instance, according to Mission Regional Medical Center (MRCM's), it is estimated that 6.7 million people currently live with chronic wounds. That number is expected to grow by more than two percent in the next decade.
  • The annual cost of chronic wounds to the healthcare system exceeds USD 50 billion. Interactive wound care aims to prevent chronic wounds and heal patients more quickly and affordably. Hence, considering the advantages of interactive wound care management, the market is anticipated to witness growth during the forecast period.
  • Furthermore, government and private agencies' initiatives associated with wound healing are likely to boost market growth. For instance, in September 2022, the Alliance of Wound Care Stakeholders urged the Centers for Medicare and Medicaid Services (CMS) to update inadequate payment methodologies for cellular and/or tissue-based products for skin wounds (CTPs, or "skin substitutes") to ensure appropriate access to care in the hospital outpatient/provider-based department (PBD) site of service.
  • Hence, such recommendations associated with interactive wound care are likely to provide a better understanding of wound care, thereby boosting the market growth over the forecast period. Moreover, market players are actively innovating new products to maintain the competition, likely promoting the market growth.
  • Winner Medical is a top original equipment manufacturer (OEM) and original design manufacturer (ODM) advanced wound care dressing manufacturer. Its wound care products have been widely used in more than 110 countries as primary solutions to provide wound management for acute and chronic wounds resulting from diabetes, immobility and venous disease, as well as from traumatic injury, burns, invasive surgery and other causes. Winner showcased its complete set latest and industry-leading advanced wound care solutions such as transparent film dressing, bordered silicone foam dressing with SAF and antibiosis series products and its new product,the CMC dressing at the European Wound Management Association (EWMA) 2022.
  • Furthermore, the rise in road accidents and casualties, which is a major source of chronic wounds, is anticipated to drive the demand for interactive wound dressing, thereby boosting market growth. For instance, according to a 2021 update from the Government of the UK, 133 deep penetrating wounds were reported from road casualties in Great Britain in 2021.
  • As a result of the increase in the number of chronic wounds and government and private sector initiatives related to wound healing, the chronic wounds segment is expected to witness growth during the forecast period.

North America is Expected to Witness a Growth in the Interactive Wound Dressing Market Over the Forecast Period

  • North America is expected to witness growth in the interactive wound dressing market owing to the factors such as the growing prevalence of chronic wounds, better healthcare infrastructure, and a rising number of surgical procedures in the region. The increase in the prevalence of diabetic populations in the country, especially in the United States, indicates that there are chances of rising diabetic ulcers.
  • As per the data published by IDF in 2021, the incidence of diabetes in Canada (per 100,000) for 2021 was around 37.9% in children aged between 0-14 years. In addition, the number of adults aged 20-79 years suffering from diabetes in Canada was around 3 million for the year 2021. Therefore, with the increasing burden of diabetes in Canada, the interactive wound care dressing market is expected to witness healthy growth over the forecast period.
  • The presence of competitors, acquisitions, and mergers boost the market growth. For instance, in March 2022, the medical products and technologies business ConvaTec Group acquired Triad Life Sciences, a US-focused medical device company. The Triad team's current portfolio and product pipeline was transferred to ConvaTec's Advanced Wound Care (AWC) business, and is now known as ConvaTec Advanced Tissue Technologies.
  • Furthermore, in October 2022, Collagen Matrix, Inc. acquired Polyganics. Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices. The acquisition expands Collagen Matrix's portfolio of bioresorbable solutions and technology platforms for bone and tissue repair, unlocking new markets and clinical opportunities for the company.
  • As a result, the growing prevalence of chronic wounds, enhanced healthcare infrastructure, and increased surgical operations are anticipated to boost North America's interactive wound dressing market over the forecast period.

Interactive Wound Dressing Market Competitor Analysis

The majority of interactive wound dressing products are being manufactured by the global key players and the market is moderately competitive in nature. Market leaders with more funds for research and better distribution system have established their position in the market. The major key players are B. Braun Melsungen AG, 3M, Cardinal Health, Inc, Smith & Nephew, and Coloplast among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Incidence of Pressure Ulcers and Diabetic Foot
    • 4.2.2 Increasing Number of Surgical Procedures
    • 4.2.3 Increasing Research and Technological Advancements in Interactive Dressings
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Advanced Interactive Wound Dressings
    • 4.3.2 Stringent Regulatory Policies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Semi-permeable Films Dressing
    • 5.1.2 Semi-permeable Foams Dressing
    • 5.1.3 Hydrogel
  • 5.2 By Application
    • 5.2.1 Acute Wounds
    • 5.2.2 Chronic Wounds
  • 5.3 By End-User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Ambulatory Surgical Centers
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Cardinal Health, Inc
    • 6.1.4 Coloplast
    • 6.1.5 Integra Lifesciences
    • 6.1.6 Johnson & Johnson
    • 6.1.7 MediWound
    • 6.1.8 Seton Pharmaceuticals
    • 6.1.9 Smith & Nephew
    • 6.1.10 PAUL HARTMANN AG
    • 6.1.11 Molnlycke Health Care AB
    • 6.1.12 Mativ Holdings (Scapa)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS